Study of breast cancer prevention by letrozole in high risk women.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 02 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Apr 2015 Planned End Date changed from 1 Jul 2014 to 1 Jul 2015, according to to ClinicalTrials.gov record.